Tectonic Therapeutic (TECX) Share-based Compensation (2017 - 2026)

Tectonic Therapeutic (TECX) has 10 years of Share-based Compensation data on file, last reported at $3.7 million in Q1 2026.

• On a quarterly basis, Share-based Compensation rose 77.37% year-over-year to $3.7 million in Q1 2026; TTM through Mar 2026 was $11.6 million, a 433.41% increase from a year earlier, with the FY2025 full-year figure at $10.5 million, down 21.08% from the prior year.
• Share-based Compensation for Q1 2026 stood at $3.7 million, up from $3.0 million in the prior quarter.
• Over the last five years, Share-based Compensation for TECX reached as high as $24.0 million in Q2 2025 and fell as low as -$2.0 million in Q4 2024.
• Historically, Share-based Compensation has averaged $2.7 million across 5 years, with a median of $1.6 million in 2024.
• Across the five-year window, Share-based Compensation jumped 252900.0% in 2023 and tumbled 771.43% in 2024, its largest moves.
• Year by year, Share-based Compensation stood at $2000.0 in 2022, then surged by 14600.0% to $294000.0 in 2023, then slumped by 771.43% to -$2.0 million in 2024, then jumped by 251.42% to $3.0 million in 2025, then climbed by 24.79% to $3.7 million in 2026.
• Per Business Quant data, the three most recent Share-based Compensation figures were $3.7 million in Q1 2026, $3.0 million in Q4 2025, and $2.8 million in Q3 2025.